![](/img/cover-not-exists.png)
MP27-06 DEVELOPMENT OF A NEW PROGNOSTIC MODEL TO PREDICT SURVIVAL OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA RECEIVING FIRST-LINE GEMCITABINE PLUS CISPLATIN CHEMOTHERAPY: MULTICENTER RETROSPECTIVE STUDY BY THE SAPPORO MEDICAL UNIVERSITY UROLOGIC ONCOLOGY CONSORTIUM (SUOC)
Maehana, Takeshi, Tanaka, Toshiaki, Shindo, Tetsuya, Takahashi, Atsushi, Ito, Naoki, Taguchi, Keisuke, Hotta, Hiroshi, Masumori, NaoyaVolume:
195
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2016.02.1037
Date:
April, 2016
File:
PDF, 365 KB
english, 2016